Skip to main content
. Author manuscript; available in PMC: 2016 Oct 18.
Published in final edited form as: Cancer. 2015 Dec 28;122(6):875–883. doi: 10.1002/cncr.29856

TABLE 2.

Toxicities for Reolysin in Combination With Paclitaxel and Carboplatin

Toxicity Reolysin Plus Paclitaxel With Carboplatin at 200mg/m2/AUC 6 (n = 2), % Reolysin Plus Paclitaxel With Carboplatin at 175 mg/m2/AUC 5 (n = 36), %

Grade 1 Grade 2 Grade 3 Grade 4 Grade 1 Grade 2 Grade 3 Grade 4
Hematologic
    Neutropenia 0 0 0 50 0 14 19 0
    Anemia 0 0 50 0 6 14 3 0
    Thrombocytopenia 0 50 0 0 14 3 3 0
    Lymphocytopenia 0 0 0 0 8 11 6 0
    Febrile neutropenia 0 0 50 0 0 0 0 0
Non hematologic
    Nausea 50 50 0 0 64 8 3 0
    Vomiting 0 0 0 0 22 8 8 0
    Anorexia 0 50 0 0 17 11 0 0
    Diarrhea 0 0 100 0 72 17 8 0
    Confusion 0 0 0 0 6 3 3 0
    Headaches 0 0 0 0 3 0 0 0
    Transaminitis 0 0 0 0 14 6 3 0
    Fatigue/asthenia 0 50 50 0 83 33 19 3
    Arthralgia 0 0 0 0 11 17 0 0
    Myalgia 0 0 0 0 17 28 0 0
    Peripheral neuropathy 50 0 0 0 14 3 0 0
    Hypotension 0 0 0 0 0 0 0 3
    Peripheral edema 0 0 50 0 3 0 0 0
    Fever 0 0 0 0 36 8 3 0

Abbreviation: AUC, area under the curve.